Home > Publishers > MP Advisors
  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Publisher
Filter

MP Advisors Report List

madv
MP Advisors is a Consultancy firm with an exclusive focus on Pharmaceuticals / Biotechnology sectors in the US, Europe, India, Japan and Russia. It was operating earlier as an international affiliate of Mehta Partners LLC since 1996. Today it has a highly motivated, qualified team of PhD's, MBA's and Pharmacist who apply their domain knowledge to develop proprietary data bases, understand dynamic regulatory laws across geographies, track and analyze latest trends in drug development, clinical trials and specific diseases. MP Advisors has insightful information on more than 200 pharma and Biotech companies around the globe as well as publishes reports on Key Opinion Leaders (Physician’s view) assessment, therapy class review of several classes (e.g. Oral anticoagulants, Hepatitis C, Obesity, Novel Drug Delivery systems, Biosimilars etc.), India and Japan generic opportunities and Paragraph IV Opportunities.

Filter
Title Search
1 - 2 of 2 Products Sort by Display
Outlook of Diabetic Macular Edema - Current Landscape and the Way Forward
Published by
MP Advisors
Product code
948143
Published
July 3, 2020
Content info
81 Pages
Price
USD 4500
Sample available
Japan Biosimilars- Landscape Today Outlook Tomorrow - "Biosame" entry, uninterrupted supply and companies' strong front-end footprint requirement makes it distinct
Published by
MP Advisors
Product code
920744
Published
January 6, 2020
Content info
156 Pages
Price
USD 4500
Sample available
Compare
item is currently selected
Compare products
Delete all